← Back to All Filings

PureCycle Appoints New Director, Grants $62.5k in RSUs

Low SignificanceNovember 3, 2025 at 9:02:32 AM EST

PureCycle Technologies, Inc.

$PCT8-KCIK: 0001830033

Subscribe to track PCT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

PureCycle Appoints New Director, Grants $62.5k in RSUs

Company: PureCycle Technologies, Inc. (PCT) Form: 8-K | Filed: 2025-11-03 Significance: Low

Insider: Dr. Siri Jirapongphan Title: Director | Relationship: Director

Event: • Appointment: Dr. Siri Jirapongphan appointed to the Board of Directors, effective Oct 28, 2025. • Resignation: Jeffrey R. Fieler resigned from the Board. • Compensation: New director granted an initial RSU award valued at $62,500, prorated for the term.

Key Insight: The filing announces a board refreshment, adding a director with deep expertise in Thai markets and chemical engineering, aligning with the company's global expansion plans. The associated RSU grant is a standard, immaterial compensatory award.

Market Context: The transaction value of the grant is negligible (<0.001%) compared to the company's $2.04B market cap, indicating this is a routine corporate governance event rather than a significant insider financial transaction.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: PureCycle Technologies, Inc. (PCT)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: PureCycle has appointed Dr. Siri Jirapongphan, a former Minister of Energy for Thailand with deep chemical engineering expertise, to its Board of Directors, signaling a focus on its international expansion. The associated RSU grant is a standard compensatory measure.
  • Market Impact: The financial transaction is immaterial to the company's market capitalization. The primary market signal is the strategic board appointment.

Company Information

FieldValue
CompanyPureCycle Technologies, Inc.
Ticker SymbolPCT
CIK0001830033
IndustryPlastics, Materials, Syn Resins & Nonvulcan Elastomers

Insider Information

FieldValue
NameDr. Siri Jirapongphan
CIKnull
Title/PositionDirector
RelationshipDirector

Transaction Details

This Form 8-K reports a material corporate event, including a compensatory grant to a new director.

FieldValue
Form Type8-K
Transaction Date2025-10-28
Transaction CodeA
Security TypeRestricted Stock Units
Shares InvolvedNot specified
Price Per ShareNot applicable
Total Value$62,500
Shares Owned AfterNot specified
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$62,500
% of Market Cap<0.01%
Shares TransactedNot specified
% of Shares Outstanding<0.01% (Estimated based on value)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $62,500 grant represents a negligible fraction of PureCycle's $2.04 billion market capitalization. This is a routine cost of governance for a company of this size.
  • Dilution Impact: As a standard prorated grant for a new director, the potential dilution from these RSUs is minimal and well within typical corporate compensation practices.
  • Transaction Significance: The financial transaction itself holds no significance for traders. The focus should be on the strategic implications of the board member's expertise, particularly regarding the company's expansion into Thailand.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The event is a routine corporate governance update. The financial value of the transaction is too small to influence stock price. The positive strategic signal of the appointment is likely already priced in or will be evaluated over the long term.

Volume & Sentiment

  • Expected Volume Impact: Minimal. This type of filing does not typically drive significant trading volume.
  • Sentiment Indicator: Neutral. The appointment is a positive development, but the resignation of another director balances the immediate sentiment.

Key Takeaways

  1. Strategic Appointment: The appointment of Dr. Jirapongphan, with his background in Thailand's energy sector and chemical engineering, strongly supports PureCycle's stated goal of global expansion, particularly its first international facility in Rayong, Thailand.
  2. Board Refreshment: The simultaneous resignation of director Jeffrey R. Fieler marks a change in the board's composition.
  3. Immaterial Transaction: The $62,500 RSU grant is a standard part of a non-employee director compensation package and is not a significant financial event for the company or a signal of insider confidence.
Topics:#SECFiling#Form8K#PCT#PureCycle#CorporateGovernance#Director#BoardofDirectors#StockMarket#Chemicals

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.